-
公开(公告)号:WO0174395A3
公开(公告)日:2002-02-07
申请号:PCT/US0110598
申请日:2001-03-30
Applicant: BAXTER INT
Inventor: KIPP JAMES E , DOTY MARK J , REBBECK CHRISTINE L , EILERT JAN Y
IPC: A61K9/08 , A61K9/00 , A61K31/34 , A61K31/343 , A61K47/04 , A61K47/10 , A61K47/12 , A61K47/18 , A61K47/20 , A61K47/26 , A61P9/06
CPC classification number: A61K9/0019 , A61K31/34 , A61K47/12
Abstract: The present invention provides an amiodarone parenteral solution suitable for intravenous administration without the necessity of dilution. The parenteral solution has an amiodarone concentration from 0.2 to 10 mg/ml and a buffer solution selected from the group consisting of lactate buffer, methanesulfonate buffer, or combinations thereof, the solution having a pH within the range from approximately 2.5 - 4.5.
Abstract translation: 本发明提供了一种适于静脉内给药而不需要稀释的胺碘酮肠胃外溶液。 肠胃外溶液具有0.2至10mg / ml的胺碘酮浓度和选自乳酸盐缓冲液,甲磺酸盐缓冲液或其组合的缓冲溶液,该溶液的pH值在约2.5-4.5的范围内。
-
公开(公告)号:AT317695T
公开(公告)日:2006-03-15
申请号:AT01923027
申请日:2001-03-30
Applicant: BAXTER INT
Inventor: KIPP JAMES E , DOTY MARK J , REBBECK CHRISTINE L , EILERT JAN Y
-
公开(公告)号:AU4976601A
公开(公告)日:2001-10-15
申请号:AU4976601
申请日:2001-03-30
Applicant: BAXTER INT
Inventor: KIPP JAMES E , DOTY MARK J , REBBECK CHRISTINE L , EILERT JAN Y
-
公开(公告)号:AU2001249766B2
公开(公告)日:2004-10-07
申请号:AU2001249766
申请日:2001-03-30
Applicant: BAXTER INT
Inventor: EILERT JAN Y , REBBECK CHRISTINE L , DOTY MARK J , KIPP JAMES E
IPC: A61K9/08 , A61K9/00 , A61K31/34 , A61K31/343 , A61K47/04 , A61K47/10 , A61K47/12 , A61K47/18 , A61K47/20 , A61K47/26 , A61P9/06 , A61K047/00 , A61K031/34 , A61K047/12 , A61K047/20
-
公开(公告)号:CA2404298A1
公开(公告)日:2001-10-11
申请号:CA2404298
申请日:2001-03-30
Applicant: BAXTER INT
Inventor: REBBECK CHRISTINE L , KIPP JAMES E , EILERT JAN Y , DOTY MARK J
IPC: A61K9/08 , A61K9/00 , A61K31/34 , A61K31/343 , A61K47/04 , A61K47/10 , A61K47/12 , A61K47/18 , A61K47/20 , A61K47/26 , A61P9/06
Abstract: The present invention provides an amiodarone parenteral solution suitable fo r intravenous administration without the necessity of dilution. The parenteral solution has an amiodarone concentration from 0.2 to 10 mg/ml and a buffer solution selected from the group consisting of lactate buffer, methanesulfonate buffer, or combinations thereof, the solution having a pH within the range from approximately 2.5 - 4.5.
-
-
-
-